Latest News｜Institute for Biotechnology and Medicine Industry│IBMI

Latest News

Date	Subject	Media
2025-09-20	Senhwa Biosciences’ CX-5461 to Launch Phase 1b/2 Clinical Trial for MYC-Abnormal Lymphomas with NCI Support	Commercial Times
2025-09-19	President Lai: NT$10 Billion Investment in Smart Healthcare to Encourage Corporate Innovation and R&D	Economic Daily News
2025-09-19	Orient Pharma Successfully Challenges Pfizer Patent; Tofacitinib Generic Expected to Launch in U.S. by 2026	Commercial Times
2025-09-19	Faster Lifesaving Access: Five Key Strategies Driving “Healthy Taiwan”	The Liberty Times
2025-09-19	TSH Biopharm Launches Taiwan’s First Generic Smoking Cessation Drug to Fill Market Gap, Expected to Hit Market in Q1 2026	Investor
2025-09-18	Acer Accelerates Healthcare AI Push as Acer Medical Unveils aiMed at IFA	Economic Daily News
2025-09-18	Innovative Platform and Intelligent Collaboration to Build a National Team for Medical AI	Economic Daily News
2025-09-18	UTHR’s Nebulized Tyvaso Achieves Success in Expanding to Third Indication, PHARMOSA BIOPHARM’s L606 Poised to Benefit	Investor
2025-09-18	Advanced Connection Technology Expands into Biomedical Cell Testing, Plans to Develop Exosome-Based Cancer Screening	MoneyDJ
2025-09-18	BRIM Biotechnology Invests NT$150 Million in Compass Bioinformatics to Seize Precision Medicine Opportunities	Commercial Times

■ Most Watched

■ Industry Watch

■ IBMI News

Information appearing on this website (images and texts, unless otherwise indicated) is the property of IBMI. To use or share, please indicate the source.

Address：9F., No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist., Taipei City , Taiwan (R.O.C.) Contact Number：(02)2655-8168 Fax：(02)2655-7978